Tsao Yu-Tzu, Wu Yi-Chang, Yang Cheng-Shu, Lin Ying-Tsun
Division of Nephrology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei 114, Taiwan.
Am J Emerg Med. 2009 Jun;27(5):629.e1-3. doi: 10.1016/j.ajem.2008.08.032.
The emergence of highly active antiretroviral therapy using combinations of reverse transcriptase and protease inhibitors ushered the dawn of a new era in management of human immunodeficiency virus infection. Immune reconstitution inflammatory syndrome is an adverse consequence of the restoration of pathogen-specific immune responses during the early phase of antiretroviral therapy. Pre-existing subclinical or opportunistic infections become apparent or even "worse" as host immunological inflammatory responses are "switched on". Major reductions in plasma viral load were associated with substantial increases in circulating CD4 T-cell lymphocyte counts and restoration of immune function. The rapid reversal in immune function gives rise to paradoxical therapeutic reaction by rebuilding host immune responses. Herein, a hidden culprit responsible for tuberculosis-associated immune reconstitution characterized by severe hypercalcemia and acute renal failure is reported, illustrating the compounded therapeutic strategy in AIDS patients.
使用逆转录酶抑制剂和蛋白酶抑制剂联合的高效抗逆转录病毒疗法的出现,迎来了人类免疫缺陷病毒感染管理新时代的曙光。免疫重建炎症综合征是抗逆转录病毒治疗早期病原体特异性免疫反应恢复的不良后果。随着宿主免疫炎症反应“开启”,先前存在的亚临床或机会性感染变得明显甚至“恶化”。血浆病毒载量的大幅降低与循环CD4 T淋巴细胞计数的显著增加以及免疫功能的恢复有关。免疫功能的快速逆转通过重建宿主免疫反应引发了矛盾的治疗反应。在此,报告了一例以严重高钙血症和急性肾衰竭为特征的与结核病相关的免疫重建的潜在元凶,阐述了艾滋病患者的综合治疗策略。